SCHEMBL16674263

SCHEMBL16674263

c1cc(-c2cccc(-c3cccc(-c4cccc(-n5c6ccccc6c6ccccc65)n4)n3)n2)nc(-c2cccc(-c3cccc(-n4c5ccccc5c5ccccc54)n3)n2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.43
L3MBTL1 Q9Y468 3/20 0.43
ATM Q13315 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.39
CCR1 P32246 2/20 0.39
CCR8 P51685 2/20 0.39
TP53 P04637 2/20 0.39
LMNA P02545 1/20 0.39
ALPL P05186 1/20 0.39
HSP90AA1 P07900 1/20 0.39
ALPI P09923 1/20 0.39
ALPG P10696 1/20 0.39
ALOX15 P16050 1/20 0.39
MAPK1 P28482 1/20 0.39
HTT P42858 1/20 0.39
CCR5 P51681 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
MKNK1 Q9BUB5 1/20 0.38
MKNK2 Q9HBH9 1/20 0.38
MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16674217 1.00 KDM4E (0.43) KDM4EL3MBTL1ATMSMN1; SMN2CCR1
SCHEMBL23196697 1.00 KDM4E (0.43) KDM4EL3MBTL1ATMSMN1; SMN2CCR1
SCHEMBL16674350 1.00 KDM4E (0.43) KDM4EL3MBTL1ATMSMN1; SMN2CCR1
SCHEMBL16674303 1.00 KDM4E (0.43) KDM4EL3MBTL1ATMSMN1; SMN2CCR1
SCHEMBL16674302 0.98 KDM4E (0.45) KDM4EL3MBTL1ATMSMN1; SMN2CCR1
SCHEMBL5114706 0.91 MEN1 (0.53) KDM4EL3MBTL1ATMSMN1; SMN2CCR1
SCHEMBL10061161 0.91 KDM4E (0.39) KDM4EL3MBTL1ATMSMN1; SMN2CCR1
SCHEMBL20865125 0.90 KDM4E (0.44) KDM4EL3MBTL1ATMSMN1; SMN2CCR1
SCHEMBL12251965 0.90 DUSP3 (0.37) KDM4EL3MBTL1ATMSMN1; SMN2CCR1
SCHEMBL12036403 0.89 KDM4E (0.38) KDM4EL3MBTL1ATMSMN1; SMN2CCR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10340460-B2 Organic electroluminescent element NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2019-07-02 US disclosed
US-20150115240-A1 ORGANIC ELECTROLUMINESCENT ELEMENT NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2015-04-30 US disclosed
US-20150115240-A1 ORGANIC ELECTROLUMINESCENT ELEMENT NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2015-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10340460-B2 Organic electroluminescent element EML4, LAGE3, ELOC KDM4E 746/4885L3MBTL1 278/4885ATM 3518/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.